MINT-EMTRICITABINE/TENOFOVIR

Identification of Mint-Emtricitabine/Tenofovir

No description

Google image searchProduct monograph

Active ingredients

emtricitabine, 200 MG

tenofovir disoproxil fumarate, 300 MG

DIN: 02521547

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: MINT PHARMACEUTICALS INC

Date: 11-AUG-2022

ATC:

• J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
• J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
• J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
• J05AR03 — TENOFOVIR DISOPROXIL AND EMTRICITABINE (ATC/DDD)

Reference brand drug: Truvada

Pharmaceutical standard: MFR

External Links for Mint-Emtricitabine/Tenofovir

Search on Google

• Mint-Emtricitabine/Tenofovir side effects
• Mint-Emtricitabine/Tenofovir dosage
• emtricitabine side effects
• emtricitabine dosage
• tenofovir disoproxil fumarate side effects
• tenofovir disoproxil fumarate dosage

Mint Pharmaceuticals Inc

Go to Mint website to see drug product details. Sometimes you can find mint-emtricitabine/tenofovir photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.